Concepedia

Robin W. Spencer

RW

36

Publications

2.8K

Citations

27

H-Index

1937

Active since

Affiliations

Pfizer (United States)(Current)

Research Canada

Massachusetts Institute of Technology

Robin W. Spencer is an author at Pfizer (United States) specializing in medicine, biochemistry, and pharmacology.

ORCID

Top concepts

Publications per year

1937–2013

36

Publications

36

A Potent Nonpeptide Antagonist of the Substance P (NK <sub>1</sub> ) Receptor

R. Michael Snider, Jay W. Constantine, John Lowe et al. · Science · 1991 · 864 citations

, , +12

Design and synthesis of 4H-3,1-benzoxazin-4-ones as potent alternate substrate inhibitors of human leukocyte elastase

Allen Krantz, Robin W. Spencer, Tim F. Tam et al. · Journal of Medicinal Chemistry · 1990 · 267 citations · Full text

Mechanism and kinetics of iron release from ferritin by dihydroflavins and dihydroflavin analogs

Tim T. Jones, Robin W. Spencer, Christopher Walsh · Biochemistry · 1978 · 196 citations

Preparation, characterization, and chemical properties of the flavin coenzyme analogues 5-deazariboflavin, 5-deazariboflavin 5'-phosphate, and 5-deazariboflavin 5'-diphosphate, 5' → 5'-adenosine ester

Robin W. Spencer, Jed F. Fisher, Christopher T. Walsh · Biochemistry · 1976 · 156 citations

Chemical and enzymic properties of riboflavin analogs

Christopher T. Walsh, Jed F. Fisher, Robin W. Spencer et al. · Biochemistry · 1978 · 144 citations

, , +14

Rows per page

1–5 of 36